Re: Efficacy of alfuzosin and sildenafil combination in male patients with lower urinary tract symptoms.
Steven A
SA
Kaplan
D058668:Adrenergic alpha-1 Receptor Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use*; D010879:Piperazines / Q000627:therapeutic use*; D011470:Prostatic Hyperplasia / Q000150:complications*; D011799:Quinazolines / Q000627:therapeutic use*; D013450:Sulfones / Q000627:therapeutic use*; D014555:Urination Disorders / Q000188:drug therapy*
D058668:Adrenergic alpha-1 Receptor Antagonists; D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011799:Quinazolines; D013450:Sulfones